Michael Mollerus

Davis Polk is advising SS&C Technologies Holdings, Inc. on its $1.5 billion acquisition of Intralinks Holdings, Inc. from affiliates of Siris Capital Group. The transaction is expected…

Davis Polk is advising Kosmos Energy Ltd. on its $1.225 billion proposed acquisition of Deep Gulf Energy from First Reserve and other shareholders. The acquisition is expected to close…

Davis Polk advised AC Immune SA in connection with its $117.5 million U.S. follow-on public offering. AC Immune sold 8,500,000 of its newly issued common shares and subscription rights…

Davis Polk is advising MSCI on its sale of InvestorForce to Resurgens Technology Partners. The transaction is expected to close within the next three months and is subject to customary…

Davis Polk advised IHS Markit Ltd. in connection with its SEC-registered offering of $1.25 billion aggregate principal amount of senior notes in two series, consisting of $500 million…

Davis Polk is advising Aptiv PLC on its acquisition of Winchester Interconnect from an affiliate of Snow Phipps Group for $650 million. The transaction is subject to regulatory approval and…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $100 million initial public offering of common stock of Magenta…

Davis Polk advised the sole book-running manager in connection with an SEC-registered common stock offering of 12,000,000 shares of common stock of Tellurian Inc. The net proceeds from…

Davis Polk is advising Roche on its acquisition of the outstanding shares of Foundation Medicine, Inc. not already owned by Roche at a price of $137.00 per share in cash. The transaction is…

Davis Polk advised the joint book-running managers in connection with the $172 million public offering of common stock of Deciphera Pharmaceuticals, Inc. The common stock is listed on…